Fredrika Killander

722 citations

25 papers · 411 indexed · h-index 12

Impact in

Cancer Research top 10%
- Breast Cancer Treatment Studies
Oncology
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research

Papers in ⓘ

Cancer Research 20
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 4
Oncology 16
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2

Co-authors: Per Malmström (8 shared papers)Per Karlsson (12 shared papers)Erik Holmberg (12 shared papers)Dan Lundstedt (7 shared papers)Elisabeth Kjellén (4 shared papers)Emma Niméus (11 shared papers)Martin Sjöström (6 shared papers)Mårten Fernö (4 shared papers)
Journals: European Journal of Cancer (5 papers)Clinical Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Molecular Oncology (2 papers)BMC Cancer (2 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

Fredrika Killander

22 papers receiving 404 citations

Peers

Countries citing papers authored by Fredrika Killander

Since Specialization

Citations

This map shows the geographic impact of Fredrika Killander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrika Killander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrika Killander more than expected).

Fields of papers citing papers by Fredrika Killander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrika Killander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrika Killander. The network helps show where Fredrika Killander may publish in the future.

Co-authors

The 25 scholars most cited alongside Fredrika Killander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fredrika Killander Line = papers co-authored together Fredrika Killander links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial Journal of Clinical Oncology ·Martin Sjöström, Dan Lundstedt, Linda Hartman, Erik Holmberg, Fredrika Killander, Anikó Kovács, Per Malmström, Emma Niméus, Elisabeth Werner Rönnerman, Mårten Fernö, Per Karlsson	2017	80
2	Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5) European Journal of Cancer ·Marie Magnusson, Peter Höglund, Karin Johansson, Charlotta Jönsson, Fredrika Killander, Per Malmström, Anna Weddig, Elisabeth Kjellén	2009	60
3	No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT European Journal of Cancer ·Fredrika Killander, Per Karlsson, H. Anderson, Jan Mattsson, Erik Holmberg, Dan Lundstedt, Lars Holmberg, Annika Malmström	2016	48
4	Molecular profiling of male breast cancer – Lost in translation? The International Journal of Biochemistry & Cell Biology ·Ida Johansson, Fredrika Killander, Barbro Linderholm, Ingrid Hedenfalk	2014	34
5	Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up British Journal of Cancer ·Julia Tutzauer, Martin Sjöström, Erik Holmberg, Per Karlsson, Fredrika Killander, L.M. Fredrik Leeb-Lundberg, Per Malmström, Emma Niméus, Mårten Fernö, Annika Jögi	2022	34
6	Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy – 25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group European Journal of Cancer ·Fredrika Killander, Harald Anderson, Elisabeth Kjellén, Per Malmström	2014	22
7	Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I European Journal of Cancer ·Fredrika Killander, Harald Anderson, Stefan Rydén, Henrik Møller, Knut Aspegren, Jeanette Ceberg, Christina Danewid, Per Malmström	2007	19
8	Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial Clinical Cancer Research ·Axel Stenmark Tullberg, Henri Puttonen, Martin Sjöström, Erik Holmberg, S. Laura Chang, Felix Y. Feng, Corey Speers, Lori J. Pierce, Dan Lundstedt, Fredrika Killander, Emma Niméus, Anikó Kovács, Per Karlsson	2020	17
9	No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial International Journal of Radiation OncologyBiologyPhysics ·Fredrika Killander, Elinore Wieslander, Per Karlsson, Erik Holmberg, Dan Lundstedt, Lars Holmberg, Linda L. Werner, Sasha Koul, Mahnaz Haghanegi, Elisabeth Kjellén, Per Nilsson, Per Malmström	2020	16
10	Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer – A randomized trial from the South Sweden Breast Cancer Group The Breast ·Fredrika Killander, Harald Anderson, Stefan Rydén, Henrik Møller, L Hafström, Per Malmström	2009	15
11	Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms Breast Cancer Research ·Gudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, Johan Hartman, Ana Bosch, Johan Staaf, Fredrika Killander, Emma Niméus	2023	14
12	Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe European Journal of Surgical Oncology ·Åsa Wickberg, Göran Liljegren, Fredrika Killander, Henrik Lindman, Judith Bjöhle, Michael Carlberg, Carl Blomqvist, Johan Ahlgren, Kenneth Villman	2018	13
13	Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes International Journal of Radiation OncologyBiologyPhysics ·Jamila Adra, Dan Lundstedt, Fredrika Killander, Erik Holmberg, Mahnaz Haghanegi, Elisabeth Kjellén, Per Karlsson, Sara Alkner	2019	11
14	Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial Journal for ImmunoTherapy of Cancer ·Axel Stenmark Tullberg, Martin Sjöström, Lena Tran, Emma Niméus, Fredrika Killander, Anikó Kovács, Dan Lundstedt, Erik Holmberg, Per Karlsson	2023	8
15	Elevation of ADP-ribosylation as an indicator of mononuclear leucocyte responsiveness in breast cancer patients treated with tamoxifen European Journal of Cancer ·Ronald W. Pero, Håkan Olsson, Fredrika Killander, Walter Troll	1992	4
16	Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017 Cancer Research ·Martin Malmberg, Christer Larsson, Johan Vallon‐Christersson, Anna Ehinger, Cecilia Hegardt, Fredrika Killander, Lisa Rydén, Lao H. Saal, Niklas Loman, Åke Borg	2020	4
17	Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial Molecular Oncology ·Moa Egelberg, Tommaso De Marchi, Gyula Pekár, Lena Tran, Pär‐Ola Bendahl, Axel Stenmark Tullberg, Erik Holmberg, Per Karlsson, Marianne Farnebo, Fredrika Killander, Emma Niméus	2023	3
18	Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial Clinical Cancer Research ·Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander, S. Laura Chang, Felix Y. Feng, Corey Speers, Lori J. Pierce, Anikó Kovács, Dan Lundstedt, Erik Holmberg, Per Karlsson	2023	2
19	Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort Clinical Cancer Research ·Rebecca J.G. Drake, Amalia H. Landén, Erik Holmberg, Axel Stenmark Tullberg, Fredrika Killander, Emma Niméus, Alexander Jordan, Jennifer R. McGuinness, Per Karlsson, Kairbaan Hodivala‐Dilke	2025	2
20	Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer BMC Cancer ·Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Par‐Ola Bendahl, Mårten Fernö	2018	2

About Fredrika Killander

Fredrika Killander is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Radiation and Immunology and Allergy, having authored 25 papers that have together received 411 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Cancer Cells and Metastasis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Breast Lesions and Carcinomas (5 papers), Cancer Genomics and Diagnostics (4 papers), HER2/EGFR in Cancer Research (3 papers), Breast Implant and Reconstruction (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (240 citations), Oncology (199 citations), Pathology and Forensic Medicine (94 citations), Radiation (26 citations) and Dermatology (25 citations). Fredrika Killander has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Per Malmström, Per Karlsson, Erik Holmberg, Dan Lundstedt, Elisabeth Kjellén, Emma Niméus, Martin Sjöström, Mårten Fernö, Harald Anderson and Anikó Kovács. Their work appears in journals such as European Journal of Cancer, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Molecular Oncology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact